@prefix this: . @prefix rdfs: . @prefix xsd: . @prefix sio: . @prefix ncit: . @prefix lld: . @prefix miriam-gene: . @prefix miriam-pubmed: . @prefix eco: . @prefix wi: . @prefix prov: . @prefix pav: . @prefix prv: . @prefix dcterms: . @prefix np: . @prefix dgn-np: . @prefix dgn-gda: . @prefix dgn-void: . dgn-np:NP24311.RA_I9BrC46jOxQ_srHmLgyJ_LVLHZ4OlvUm5cDtCnMIzI130_head { this: np:hasAssertion dgn-np:NP24311.RA_I9BrC46jOxQ_srHmLgyJ_LVLHZ4OlvUm5cDtCnMIzI130_assertion; np:hasProvenance dgn-np:NP24311.RA_I9BrC46jOxQ_srHmLgyJ_LVLHZ4OlvUm5cDtCnMIzI130_provenance; np:hasPublicationInfo dgn-np:NP24311.RA_I9BrC46jOxQ_srHmLgyJ_LVLHZ4OlvUm5cDtCnMIzI130_publicationInfo; a np:Nanopublication . dgn-np:NP24311.RA_I9BrC46jOxQ_srHmLgyJ_LVLHZ4OlvUm5cDtCnMIzI130_assertion a np:Assertion . dgn-np:NP24311.RA_I9BrC46jOxQ_srHmLgyJ_LVLHZ4OlvUm5cDtCnMIzI130_provenance a np:Provenance . dgn-np:NP24311.RA_I9BrC46jOxQ_srHmLgyJ_LVLHZ4OlvUm5cDtCnMIzI130_publicationInfo a np:PublicationInfo . } dgn-np:NP24311.RA_I9BrC46jOxQ_srHmLgyJ_LVLHZ4OlvUm5cDtCnMIzI130_assertion { miriam-gene:4843 a ncit:C16612 . lld:C0566602 a ncit:C7057 . dgn-gda:DGN08e2902ba547b90361107bf8d21f74ff sio:SIO_000628 miriam-gene:4843, lld:C0566602; a sio:SIO_001121 . } dgn-np:NP24311.RA_I9BrC46jOxQ_srHmLgyJ_LVLHZ4OlvUm5cDtCnMIzI130_provenance { dgn-np:NP24311.RA_I9BrC46jOxQ_srHmLgyJ_LVLHZ4OlvUm5cDtCnMIzI130_assertion dcterms:description "[Our results show that: (1) tumor necrosis factor (TNF)-alpha, and interferon (IFN)-gamma, synergically stimulate NO production in cultured cholangiocytes through an increase in NOS2 gene and protein expression; (2) micromolar concentrations of NO inhibit forskolin-stimulated cAMP production by adenylyl cyclase (AC), cyclic adenosine monophosphate (cAMP)-dependent fluid secretion, and cAMP-dependent Cl(-) and HCO(3)(-) transport mediated by cystic fibrosis transmembrane conductance regulator (CFTR) and anion exchanger isoform 2, respectively; (3) cholestatic effects of NO and of proinflammatory cytokines are prevented by NOS-2 inhibitors and by agents (manganese(III)-tetrakis(4-benzoic acid)porphyrin [MnTBAP], urate, trolox) able to block the formation of reactive nitrogen oxide species (RNOS); (4) NOS2 expression is increased significantly in the biliary epithelium of patients with primary sclerosing cholangitis (PSC).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en; wi:evidence dgn-void:source_evidence_curated; sio:SIO_000772 miriam-pubmed:12612912; prov:wasDerivedFrom dgn-void:ctd_human-20130708; prov:wasGeneratedBy eco:ECO_0000218 . dgn-void:ctd_human-20130708 pav:importedOn "2013-07-24"^^xsd:date . dgn-void:source_evidence_curated a eco:ECO_0000205; rdfs:comment "Gene-disease associations manually curated."@en; rdfs:label "DisGeNET evidence - CURATED"@en . } dgn-np:NP24311.RA_I9BrC46jOxQ_srHmLgyJ_LVLHZ4OlvUm5cDtCnMIzI130_publicationInfo { this: dcterms:created "2014-10-02T12:32:09+02:00"^^xsd:dateTime; dcterms:rights ; dcterms:rightsHolder dgn-void:IBIGroup; dcterms:subject sio:SIO_000983; prv:usedData dgn-void:disgenetrdf; pav:authoredBy , , , , ; pav:createdBy ; pav:version "v2.1.0.0" . dgn-void:disgenetrdf pav:version "v2.1.0" . }